ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $9,492,000 | -24.3% | 234,831 | +7.8% | 0.01% | -17.6% |
| Q2 2015 | $12,540,000 | -48.1% | 217,885 | -42.6% | 0.02% | -50.0% |
| Q1 2015 | $24,165,000 | +8.9% | 379,530 | +5.6% | 0.03% | +3.0% |
| Q4 2014 | $22,180,000 | +63.1% | 359,236 | +2.6% | 0.03% | +50.0% |
| Q3 2014 | $13,597,000 | +14.6% | 350,159 | +1.7% | 0.02% | +10.0% |
| Q2 2014 | $11,867,000 | -19.5% | 344,459 | +1.0% | 0.02% | -23.1% |
| Q1 2014 | $14,743,000 | +4.6% | 341,177 | -3.6% | 0.03% | -3.7% |
| Q4 2013 | $14,098,000 | +28.5% | 353,862 | +22.4% | 0.03% | +22.7% |
| Q3 2013 | $10,972,000 | -6.4% | 289,041 | -29.8% | 0.02% | -15.4% |
| Q2 2013 | $11,719,000 | – | 411,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |